UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Cell, 2021-04, Vol.184 (9), p.2384-2393.e12

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Cell, 2020-05, Vol.181 (5), p.1016-1035.e19

2020

Link zum Volltext

Verfügbarkeit prüfen

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1351

2022

Link zum Volltext

Verfügbarkeit prüfen

Smoking and COVID-19: Adding Fuel to the Flame

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6581

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of inhaled pollutants on response to viral infection in controlled exposures

Journal of allergy and clinical immunology, 2021-12, Vol.148 (6), p.1420-1429

2021

Link zum Volltext

Verfügbarkeit prüfen

VPS29 Exerts Opposing Effects on Endocytic Viral Entry

mBio, 2022-04, Vol.13 (2), p.e0300221-e0300221

2022

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Pharmacology & therapeutics (Oxford), 2020-09, Vol.213, p.107587-107587, Article 107587

2020

Link zum Volltext

Verfügbarkeit prüfen

Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19

European journal of medicinal chemistry, 2021-12, Vol.226, p.113857-113857, Article 113857

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

PLoS pathogens, 2021-02, Vol.17 (2), p.e1009225

2021

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

Cellular and molecular life sciences : CMLS, 2022-03, Vol.79 (3), p.142-142, Article 142

2022

Link zum Volltext

Verfügbarkeit prüfen

Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10475

2023

Link zum Volltext

Verfügbarkeit prüfen

Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection

The Journal of biological chemistry, 2021-01, Vol.296, p.100135-100135, Article 100135

Fuentes-Prior, Pablo

2021

Link zum Volltext

Verfügbarkeit prüfen

Peptide-Based Vaccines and Therapeutics for COVID-19

International journal of peptide research and therapeutics, 2022-05, Vol.28 (3), p.94-94, Article 94

2022

Link zum Volltext

Verfügbarkeit prüfen

The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial

Cell transplantation, 2021, Vol.30, p.96368972110249-9636897211024942

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction

Journal of virology, 2021-04, Vol.95 (10)

2021

Link zum Volltext

Verfügbarkeit prüfen

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

Virology journal, 2021-07, Vol.18 (1), p.154-154, Article 154

2021

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibodies targeting SARS-CoV-2 spike protein

Stem cell research, 2021-01, Vol.50, p.102125-102125, Article 102125

2021

Link zum Volltext

Verfügbarkeit prüfen

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Pharmacological research, 2022-08, Vol.182, p.106334-106334, Article 106334

2022

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

Life sciences (1973), 2020-12, Vol.262, p.118493-11, Article 118493

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7365

2022

Link zum Volltext

Verfügbarkeit prüfen

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Biotechnology letters, 2022-02, Vol.44 (2), p.159-177

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells

Virology (New York, N.Y.), 2022-04, Vol.569, p.1-12

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Membrane protein regulates the function of Spike by inhibiting its plasma membrane localization and enzymatic activity of Furin

Microbiological research, 2024-05, Vol.282, p.127659-127659, Article 127659

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic modalities and novel approaches in regenerative medicine for COVID-19

International journal of antimicrobial agents, 2020-12, Vol.56 (6), p.106208-106208, Article 106208

2020

Link zum Volltext

Verfügbarkeit prüfen

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Phytotherapy research, 2021-02, Vol.35 (2), p.908-919

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaCovid-19

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(32)
Sars-Cov-2
(28)
Coronaviruses
(23)
Severe Acute Respiratory Syndrome Coronavirus 2
(19)
Pandemics
(17)
Review
(16)
Ace2
(13)
Biochemistry & Molecular Biology
(11)
Cell Biology
(11)
Mesenchymal Stem Cells
(10)
Stem Cells
(10)
Viral Diseases
(10)
Angiotensin-Converting Enzyme 2
(9)
Covid-19 - Therapy
(9)
Covid-19 - Virology
(9)
Cytokines
(9)
Life Sciences
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment

Smoking and COVID-19: Adding Fuel to the Flame

Impact of inhaled pollutants on response to viral infection in controlled exposures

VPS29 Exerts Opposing Effects on Endocytic Viral Entry

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein

Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection

Peptide-Based Vaccines and Therapeutics for COVID-19

The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial

SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

Neutralizing antibodies targeting SARS-CoV-2 spike protein

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells

SARS-CoV-2 Membrane protein regulates the function of Spike by inhibiting its plasma membrane localization and enzymatic activity of Furin

Therapeutic modalities and novel approaches in regenerative medicine for COVID-19

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Aktive Filter

Suchergebnisse filtern